Progression-free survival in patients with 68Ga-PSMA-PET-directed SBRT for lymph node oligometastases.
Anita M Werensteijn-HoninghAnne F J WeversMax PetersPetra S KroonMartijn P W IntvenWietse S C EppingaIna M Jürgenliemk-SchulzPublished in: Acta oncologica (Stockholm, Sweden) (2021)
A median PFS of 16 months was attained after SBRT for patients with PSMA-PET positive oligometastatic lymph nodes from prostate cancer. Higher pre-SBRT PSA, younger age and extrapelvic location were found to be predictors of shorter PFS.